Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Crohn's Disease (CD) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Crohn’s Disease (CD) Key assessments Patient Segmentation in Crohn’s Disease (CD) Crohn’s Disease (CD) Risk & Burden Factors driving growth in a specific Crohn’s Disease (CD) patient population
January 2022
60 pages
Cystic fibrosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 10 Year Forecast 7MM Coverage Total Cases in Cystic fibrosis Epidemiology Forecast Key assessments Patient Segmentation in Cystic fibrosis Epidemiology Forecast Cystic fibrosis Epidemiology Forecast Risk & Burden Factors driving growth in a specific Cystic fibrosis Epidemiology Forecast patient population
January 2022
60 pages
Cytomegalovirus (CMV) Infection - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cytomegalovirus (CMV) Infection Key assessments Patient Segmentation in Cytomegalovirus (CMV) Infection Cytomegalovirus (CMV) Infection Risk & Burden Factors driving growth in a specific Cytomegalovirus (CMV) Infection patient ...
January 2022
60 pages
Dermatophytic Onychomycosis - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dermatophytic Onychomycosis Key assessments Patient Segmentation in Dermatophytic Onychomycosis Dermatophytic Onychomycosis Risk & Burden Factors driving growth in a specific Dermatophytic Onychomycosis patient population
January 2022
60 pages
Diabetic Foot Ulcers (DFUs) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic foot ulcers (DFUs) Key assessments Patient Segmentation in Diabetic foot ulcers (DFUs) Diabetic foot ulcers (DFUs) Risk & Burden Factors driving growth in a specific Diabetic foot ulcers (DFUs) patient population
January 2022
60 pages
Diabetic Gastroparesis - Epidemiology Forecast-2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic Gastroparesis Key assessments Patient Segmentation in Diabetic Gastroparesis Diabetic Gastroparesis Risk & Burden Factors driving growth in a specific Diabetic Gastroparesis patient population
January 2022
60 pages
Diabetic Macular Edema (DME) - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic Macular Edema (DME) Key assessments Patient Segmentation in Diabetic Macular Edema (DME) Diabetic Macular Edema (DME) Risk & Burden Factors driving growth in a specific Diabetic Macular Edema (DME) patient population
January 2022
60 pages
Diabetic Nephropathy - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic Nephropathy Key assessments Patient Segmentation in Diabetic Nephropathy Diabetic Nephropathy Risk & Burden Factors driving growth in a specific Diabetic Nephropathy patient population
January 2022
60 pages
Dry eye disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dry eye disease Key assessments Patient Segmentation in Dry eye disease Dry eye disease Risk & Burden Factors driving growth in a specific Dry eye disease patient population
January 2022
60 pages
Duchenne Muscular Dystrophy - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Duchenne Muscular Dystrophy Key assessments Patient Segmentation in Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Risk & Burden Factors driving growth in a specific Duchenne Muscular Dystrophy patient population
January 2022
60 pages
Dyslipidemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dyslipidemia Key assessments Patient Segmentation in Dyslipidemia Dyslipidemia Risk & Burden Factors driving growth in a specific Dyslipidemia patient population
January 2022
60 pages
Dysmenorrhea - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dysmenorrhea Key assessments Patient Segmentation in Dysmenorrhea Dysmenorrhea Risk & Burden Factors driving growth in a specific Dysmenorrhea patient population
January 2022
60 pages
Eczema - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Eczema Key assessments Patient Segmentation in Eczema Eczema Risk & Burden Factors driving growth in a specific Eczema patient population
January 2022
60 pages
Endometrial Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Endometrial Cancer Key assessments Patient Segmentation in Endometrial Cancer Endometrial Cancer Risk & Burden Factors driving growth in a specific Endometrial Cancer patient population
January 2022
60 pages
Epilepsy - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Epilepsy Key assessments Patient Segmentation in Epilepsy Epilepsy Risk & Burden Factors driving growth in a specific Epilepsy patient population
January 2022
60 pages
Ewing Sarcoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Ewing Sarcoma Key assessments Patient Segmentation in Ewing Sarcoma Ewing Sarcoma Risk & Burden Factors driving growth in a specific Ewing Sarcoma patient population
January 2022
60 pages
Fibromyalgia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Fibromyalgia Key assessments Patient Segmentation in Fibromyalgia Fibromyalgia Risk & Burden Factors driving growth in a specific Fibromyalgia patient population
January 2022
60 pages
Gallbladder Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gallbladder Cancer Key assessments Patient Segmentation in Gallbladder Cancer Gallbladder Cancer Risk & Burden Factors driving growth in a specific Gallbladder Cancer patient population
January 2022
60 pages
Gastric Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastric Cancer Key assessments Patient Segmentation in Gastric Cancer Gastric Cancer Risk & Burden Factors driving growth in a specific Gastric Cancer patient population
January 2022
60 pages
Gastroesophageal Reflux Disease (GERD) - Epidemiology Forecast to 2032
US$ 3,950.00
... Year Forecast 7MM Coverage Total Cases in Gastroesophageal Reflux Disease (GERD) Key assessments Patient Segmentation in Gastroesophageal Reflux Disease (GERD) Gastroesophageal Reflux Disease (GERD) Risk & Burden Factors driving growth in a specific Gastroesophageal Reflux Disease (GERD) patient population
January 2022
60 pages
Gaucher's disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gaucher’s disease Key assessments Patient Segmentation in Gaucher’s disease Gaucher’s disease Risk & Burden Factors driving growth in a specific Gaucher’s disease patient population
January 2022
60 pages
Genital Herpes - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Genital Herpes Key assessments Patient Segmentation in Genital Herpes Genital Herpes Risk & Burden Factors driving growth in a specific Genital Herpes patient population
January 2022
60 pages
Glaucoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Glaucoma Key assessments Patient Segmentation in Glaucoma Glaucoma Risk & Burden Factors driving growth in a specific Glaucoma patient population
January 2022
60 pages
Glioblastoma Multiforme (GBM) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Glioblastoma multiforme (GBM) Key assessments Patient Segmentation in Glioblastoma multiforme (GBM) Glioblastoma multiforme (GBM) Risk & Burden Factors driving growth in a specific Glioblastoma multiforme (GBM) patient population ...
January 2022
60 pages
Glioma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Glioma Key assessments Patient Segmentation in Glioma Glioma Risk & Burden Factors driving growth in a specific Glioma patient population
January 2022
60 pages
Graves Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Graves Disease Key assessments Patient Segmentation in Graves Disease Graves Disease Risk & Burden Factors driving growth in a specific Graves Disease patient population
January 2022
60 pages
Growth Hormone Deficiency (GHD) - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Growth Hormone Deficiency (GHD) Key assessments Patient Segmentation in Growth Hormone Deficiency (GHD) Growth Hormone Deficiency (GHD) Risk & Burden Factors driving growth in a specific Growth Hormone Deficiency (GHD) patient ...
January 2022
60 pages
Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Guillain-Barre Syndrome (GBS) Key assessments Patient Segmentation in Guillain-Barre Syndrome (GBS) Guillain-Barre Syndrome (GBS) Risk & Burden Factors driving growth in a specific Guillain-Barre Syndrome (GBS) patient population ...
January 2022
60 pages
H1N1 (Swine Influenza) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in H1N1 (Swine Influenza) Key assessments Patient Segmentation in H1N1 (Swine Influenza) H1N1 (Swine Influenza) Risk & Burden Factors driving growth in a specific H1N1 (Swine Influenza) patient population
January 2022
60 pages
Head and Neck cancer (HNC) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Head and Neck cancer (HNC) Key assessments Patient Segmentation in Head and Neck cancer (HNC) Head and Neck cancer (HNC) Risk & Burden Factors driving growth in a specific Head and Neck cancer (HNC) patient population ...
January 2022
60 pages
Hemophilia - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... in Hemophilia Hemophilia Pipeline Analysis Hemophilia Market Size and Trends Hemophilia Market Opportunities Impact of upcoming Therapies in Hemophilia Hemophilia Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hemophilia ...
January 2022
200 pages
Hemophilia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hemophilia Key assessments Patient Segmentation in Hemophilia Hemophilia Risk & Burden Factors driving growth in a specific Hemophilia patient population
January 2022
60 pages
Hereditary Angioedema - Epidemiology Forecast to 2032
US$ 3,950.00
... 48 hours DelveInsight’s “Hereditary Angioedema -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Hereditary Angioedema in seven major markets ... Hereditary Angioedema market. Identifying prevalent patient populations as well as risk factors in the global Hereditary Angioedema ...
January 2022
60 pages
Herpes Simplex - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population The report provides the segmentation of the disease epidemiology by types and diagnosed prevalent cases of HSV infections in 7MM Key strengths 10 Year Forecast of HSV infections epidemiology 7MM ...
January 2022
60 pages
Herpes Zoster - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Herpes Zoster Key assessments Patient Segmentation in Herpes Zoster Herpes Zoster Risk & Burden Factors driving growth in a specific Herpes Zoster patient population
January 2022
60 pages
HIV-associated Lipodystrophy - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in HIV-associated Lipodystrophy Key assessments Patient Segmentation in HIV-associated Lipodystrophy HIV-associated Lipodystrophy Risk & Burden Factors driving growth in a specific HIV-associated Lipodystrophy patient population
January 2022
60 pages
Hodgkin's lymphoma (HL) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hodgkin’s lymphoma (HL) Key assessments Patient Segmentation in Hodgkin’s lymphoma (HL) Hodgkin’s lymphoma (HL) Risk & Burden Factors driving growth in a specific Hodgkin’s lymphoma (HL) patient population
January 2022
60 pages
Human Papillomavirus (HPV) Associated Disorders - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Human Papillomavirus (HPV) Associated Disorders Key assessments Patient Segmentation in Human Papillomavirus (HPV) Associated Disorders Human Papillomavirus (HPV) Associated Disorders Risk & Burden Factors driving growth ...
January 2022
60 pages
Huntington's Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Huntington's Disease Key assessments Patient Segmentation in Huntington's Disease Huntington's Disease Risk & Burden Factors driving growth in a specific Huntington's Disease patient population
January 2022
60 pages
Hypercholesterolemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hypercholesterolemia Key assessments Patient Segmentation in Hypercholesterolemia Hypercholesterolemia Risk & Burden Factors driving growth in a specific Hypercholesterolemia patient population
January 2022
60 pages
Insomnia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Insomnia Key assessments Patient Segmentation in Insomnia Insomnia Risk & Burden Factors driving growth in a specific Insomnia patient population
January 2022
60 pages
Irritable Bowel Syndrome (IBS) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Irritable Bowel Syndrome (IBS) Key assessments Patient Segmentation in Irritable Bowel Syndrome (IBS) Irritable Bowel Syndrome (IBS) Risk & Burden Factors driving growth in a specific Irritable Bowel Syndrome (IBS) patient ...
January 2022
60 pages
Juvenile Idiopathic arthritis (JIA) - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Juvenile Idiopathic arthritis (JIA) Key assessments Patient Segmentation in Juvenile Idiopathic arthritis (JIA) Juvenile Idiopathic arthritis (JIA) Risk & Burden Factors driving growth in a specific Juvenile Idiopathic arthritis (JIA) patient population
January 2022
60 pages
Kawasaki Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Kawasaki Disease Key assessments Patient Segmentation in Kawasaki Disease Kawasaki Disease Risk & Burden Factors driving growth in a specific Kawasaki Disease patient population
January 2022
60 pages
Larynx Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Larynx Cancer Key assessments Patient Segmentation in Larynx Cancer Larynx Cancer Risk & Burden Factors driving growth in a specific Larynx Cancer patient population
January 2022
60 pages
Late-stage chronic kidney disease (CKD) - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Late-stage chronic kidney disease (CKD) Key assessments Patient Segmentation in Late-stage chronic kidney disease (CKD) Late-stage chronic kidney disease (CKD) Risk & Burden Factors driving growth in a specific Late-stage chronic kidney disease (CKD) patient population ...
January 2022
60 pages
Lennox Gastaut Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Lennox Gastaut Syndrome Key assessments Patient Segmentation in Lennox Gastaut Syndrome Lennox Gastaut Syndrome Risk & Burden Factors driving growth in a specific Lennox Gastaut Syndrome patient population
January 2022
60 pages
Lip and Oral Cavity Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Lip and Oral Cavity Cancer Key assessments Patient Segmentation in Lip and Oral Cavity Cancer Lip and Oral Cavity Cancer Risk & Burden Factors driving growth in a specific Lip and Oral Cavity Cancer patient population ...
January 2022
60 pages
Liver cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liver cancer Key assessments Patient Segmentation in Liver cancer Liver cancer Risk & Burden Factors driving growth in a specific Liver cancer patient population
January 2022
60 pages
Liver Cirrhosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liver Cirrhosis Key assessments Patient Segmentation in Liver Cirrhosis Liver Cirrhosis Risk & Burden Factors driving growth in a specific Liver Cirrhosis patient population
January 2022
60 pages
